IP Library Granted Patent US 12,472,339
Granted Patent B2
US 12,472,339 · App. 17/754,564 · Granted Nov 18, 2025

Implantable access device for accessing the vascular system of a human or animal body, particularly subcutaneously implantable access port

Inventors: Stanislas Marie Achard De La Vente (Canton de Neuchâtel, CH); Cyril Bergeon (Villers le lac, FR)
Assignee: PFM Medical GmbH
A61M39/0208A61M39/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,472,339
App. No.
17/754,564
Granted
Nov 18, 2025
Kind
B2
Abstract

A subcutaneously implantable access device for accessing a vascular system of a human or animal body. The implantable access device includes a port body, a needle entrance with at least one inlet opening for receiving a needle and an outlet opening, and an at least partially flexible catheter for accessing the vascular system of the human or animal body. The at least partially flexible catheter is connected to the outlet opening of the needle entrance, and the needle entrance is connected to the port body and movable relative to the port body between a first, unactuated operating condition that prevents fluid flow through the at least partially flexible catheter and a second, actuated operating condition that allows the fluid flow through the at least partially flexible catheter.

Claims (17)

1 . A subcutaneously implantable access device for accessing a vascular system of a human or animal body, the implantable access device comprising:

a port body;

a needle entrance with at least one inlet opening for receiving a needle and an outlet opening;

an at least partially flexible catheter for accessing the vascular system of the human or animal body connected to the outlet opening of the needle entrance,

wherein the needle entrance is connected to the port body and movable relative to the port body between a first, unactuated operating condition and a second, actuated operating condition;

further comprising clamping means for clamping the at least partially flexible catheter in the first, unactuated operating condition and unclamping the at least partially flexible catheter in the second, actuated operating condition, so that in the first, unactuated operating condition the clamping means prevent a fluid flow through the at least partially flexible catheter and in the second, actuated operating condition allow the fluid flow through the at least partially flexible catheter; and

wherein the movement of the needle entrance relative to the port body from the first, unactuated operating condition to the second, actuated operating condition comprises first a translational movement in a direction of an insertion of the needle into the needle entrance and afterwards a pivoting movement with respect to the translational movement.

2 . The device according to claim 1 , further comprising guiding means for guiding the movement between the port body and the needle entrance.

3 . The device according to claim 2 , wherein the guiding means are implemented by a separate component arranged between the port body and the needle entrance.

4 . The device according to claim 2 , wherein the guiding means are designed to lock the needle entrance in the first, unactuated operating condition and in the second, actuated operating condition.

5 . The device according to claim 4 , comprising a spring arranged between the port body and the clamping means configured to lock the clamping means in the first, unactuated operating condition and/or in the second, actuated operating condition.

6 . The device according to claim 1 , wherein the clamping means further comprise a rotation driver for rotationally connecting the clamping means to the needle entrance or separate guiding means.

7 . The device according to claim 1 , wherein the at least one inlet opening of the needle entrance comprises a funnel to guide the needle into the needle entrance.

8 . The device according to claim 1 , further comprising a flexible socket between the port body and the needle entrance.

9 . The device according to claim 1 , further comprising strain relief for the at least partially flexible catheter, which is attached to the port body.

10 . The device according to claim 1 , wherein the clamping means comprise at least two jaws for clamping the at least partially flexible catheter, the at least two jaws being arranged on opposing sides of the at least partially flexible catheter.

11 . The device according to claim 10 , wherein the clamping means further comprise a cam follower designed to cooperate with cam slopes of the port body to push the at least two jaws towards the at least partially flexible catheter in the first, unactuated operating condition and release the at least two jaws from the at least partially flexible catheter in the second, actuated operating condition.

Assignments (2)
CHANGE OF NAME Recorded Oct 31, 2024
From: PFM MEDICAL AG
To: PFM MEDICAL GMBH
Reel/Frame 069282/0994 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2022
From: ACHARD DE LA VENTE, STANISLAS MARIE; BERGEON, CYRIL
To: PFM MEDICAL AG
Reel/Frame 059527/0286 →
Priority Claims (1)
IT 102019000019761 · Oct 24, 2019 · national
Continuity (1)
Related Publication 20240058589A1 · Feb 22, 2024
References Cited (35)
US 4861341A · Woodburn · 1989 [cited by applicant]
US 5350360A · Ensminger et al. · 1994 [cited by applicant]
US 5352204A · Ensminger · 1994 [cited by applicant]
US 5356381A · Ensminger et al. · 1994 [cited by applicant]
US 5741228A · Lambrecht et al. · 1998 [cited by applicant]
US 5848989A · Villani · 1998 [cited by applicant]
US 5911706A · Estabrook et al. · 1999 [cited by applicant]
US 6007516A · Burbank et al. · 1999 [cited by applicant]
US 6056717A · Finch et al. · 2000 [cited by applicant]
US 6120492A · Finch et al. · 2000 [cited by applicant]
US 6193684B1 · Burbank et al. · 2001 [cited by applicant]
US 6506182B2 · Estabrook et al. · 2003 [cited by applicant]
US 6565525B1 · Burbank et al. · 2003 [cited by applicant]
US 7056316B1 · Burbank et al. · 2006 [cited by applicant]
US 10307581B2 · Hibdon et al. · 2019 [cited by applicant]
US 10746035B2 · Frey · 2020 [cited by applicant]
US 20050131325A1 · Chen et al. · 2005 [cited by applicant]
US 20070016162A1 · Burbank et al. · 2007 [cited by applicant]
US 20090306606A1 · Lancette et al. · 2009 [cited by applicant]
US 20100286615A1 · Gyrn et al. · 2010 [cited by applicant]
US 20190232035A1 · Fedor et al. · 2019 [cited by applicant]
CN 106413776 · 2017 [cited by applicant]
DE 19624320 · 1997 [cited by applicant]
EP 0332943 · 1989 [cited by applicant]
EP 1016431 · 2000 [cited by applicant]
EP 1245247 · 2002 [cited by applicant]
EP 1629862 · 2006 [cited by applicant]
EP 1765456 · 2011 [cited by applicant]
EP 3381501 · 2018 [cited by applicant]
WO 0132141 · 2001 [cited by applicant]
WO 2012064881 · 2012 [cited by applicant]
International Search Report from corresponding PCT Appln. No. PCT/EP2020/077511, dated Oct. 26, 2020. [cited by applicant]
Written Opinion from corresponding PCT Appln. No. PCT/EP2020/077511, dated Oct. 26, 2020. [cited by applicant]
Office Action from related Chinese Appln. No. 2020800702633, dated Oct. 23, 2020. English translation attached. [cited by applicant]
Office Action from related Japanese Appln. No. 2022-521389, dated May 9, 2023. English translation attached. [cited by applicant]